Intrasteric control of AMPK via the γ1 subunit AMP allosteric regulatory site

Protein Science

Volumn 13, Issue 1, 2004, Pages 155-165

  Adams, Julian ^a   Chen, Zhi Ping ^a   Van Denderen, Bryce J W ^a   Morton, Craig J ^a   Parker, Michael W ^a   Witters, Lee A ^b,c   Stapleton, David ^a   Kemp, Bruce E ^a  

^a ST VINCENT'S INSTITUTE OF MEDICAL RESEARCH   (Australia)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c Dartmouth College   (United States)

Author keywords

subunit; Allosteric and intrasteric control; AMP; AMPK; CBS sequences

Indexed keywords

ARGININE; CYSTATHIONINE BETA SYNTHASE; GLUTAMINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INOSINATE DEHYDROGENASE;

ALLOSTERISM; ALPHA CHAIN; ARTICLE; CRYSTAL STRUCTURE; ENZYME ACTIVITY; ENZYME BINDING; ENZYME PHOSPHORYLATION; ENZYME REGULATION; GENE MUTATION; GLYCOGEN STORAGE DISEASE; PHENOTYPE; PRIORITY JOURNAL;

ADENOSINE MONOPHOSPHATE; ADENOSINE TRIPHOSPHATE; ALLOSTERIC SITE; AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMALS; BINDING SITES; CERCOPITHECUS AETHIOPS; CONSERVED SEQUENCE; COS CELLS; ENZYME ACTIVATION; GLYCINE; HYDROGEN BONDING; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; MUTAGENESIS, SITE-DIRECTED; PHOSPHORYLATION; POINT MUTATION; PROTEIN BINDING; PROTEIN KINASES; PROTEIN STRUCTURE, TERTIARY; PROTEIN SUBUNITS; SEQUENCE HOMOLOGY, AMINO ACID;

SUS SCROFA;

EID: 0346102907     PISSN: 09618368     EISSN: None     Source Type: Journal    
DOI: 10.1110/ps.03340004     Document Type: Article

References (52)

1. Adams, J.A. 2003. Activation loop phosphorylation and catalysis in protein kinases: Is there functional evidence for the autoinhibitor model? Biochemistry 42: 601-607.
2. Barthel, A., Schmoll, D., Kruger, K.D., Roth, R.A., and Joost, H.G. 2002. Regulation of the forkhead transcription factor FKHR (FOXO1a) by glucose starvation and AICAR, an activator of AMP-activated protein kinase. Endocrinology 143: 3183-3186.
3. Bateman, A. 1997. The structure of a domain common to archaebacteria and the homocystinuria disease protein. Trends Biochem. Sci. 22: 12-13.
4. Blair, E., Redwood, C., Ashrafian H., Oliveira, M., Broxholme, J., Kerr, B., Salmon, A., Ostman-Smith, I., and Watkins, H. 2001. Mutations in the γ(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: Evidence for the central role of energy compromise in disease pathogenesis. Hum. Mol. Genet. 10: 1215-1220.
5. Cannon, J.F., Pringle, J.R., Fiechter, A., and Khalil, M. 1994. Characterization of glycogen-deficient glc mutants of Saccharomyces cerevisiae. Genetics 136: 485-503.
6. CCP4. 1994. The CCP4 suite: Programs for protein crystallography. Acta Crystallogr. D 50: 760-763.
7. Cheung, P.C., Salt, I.P., Davies, S.P., Hardie, D.G., and Carling, D. 2000. Characterization of AMP-activated protein kinase γ-subunit isoforms and their role in AMP binding. Biochem. J. 346: 659-669.
8. Daniel, T. and Carling, D. 2002. Functional analysis of mutations in the γ 2 subunit of AMP-activated protein kinase associated with cardiac hypertrophy and Wolff-Parkinson-White syndrome. J. Biol. Chem. 277: 51017-51024.
9. Davies, S.P., Helps, N.R., Cohen, P.T., and Hardie, D.G. 1995. 5′-AMP inhibits dephosphorylation, as well as promoting phosphorylation, of the AMP-activated protein kinase. Studies using bacterially expressed human protein phosphatase-2C α and native bovine protein phosphatase-2AC. FEBS Lett 377: 421-425
10. Dyck, J.R.B., Gao, G., Widmer, J., Stapleton, D., Fernandez, C.S., Kemp, B.E., and Witters, L.A. 1996. Regulation of 5′-AMP-activated protein kinase activity by the noncatalytic β and γ subunits. J. Biol. Chem. 271: 17798-17803.
11. Evande, R., Blom, H., Boers, G.H., and Banerjee, R. 2002. Alleviation of intrasteric inhibition by the pathogenic activation domain mutation, D444N, in human cystathionine β-synthase. Biochemistry 41: 11832-11837.
12. Ferre, P., Azzout-Marniche, D., and Foufelle, F. 2003, AMP-activated protein kinase and hepatic genes involved in glucose metabolism, Biochem. Soc. Trans, 31: 220-223.
13. Frederich, M. and Balschi, J.A. 2002. The relationship between AMP-activated protein kinase activity and AMP concentration in the isolated perfused rat heart. J. Biol. Chem. 277: 1928-1932.
14. Fryer, L.G., Parbu-Patel, A., and Carling, D. 2002. The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways. J. Biol. Chem. 277: 25226-25232.
15. Gao, G., Fernandez, C.S., Stapleton, D., Auster, A.S., Widmer, J., Dyck, J.R., Kemp, B.E., and Witters, L.A. 1996. Non-catalytic β- and γ-subunit isoforms of the 5′-AMP-activated protein kinase. J. Biol. Chem. 271: 8675-8681.
16. Glass, D.B., Masaracchia, R.A., Feramisco, J.R., and Kemp, B.E. 1978. Isolation of phosphorylated peptides and proteins on ion exchange papers. Anal. Biochem. 87: 566-575.
17. Gollob, M.H., Seger, J.J., Gollob, T.N., Tapscott, T., Gonzales, O., Bachinski, L., and Roberts, R. 2001. Novel PRKAG2 mutation responsible for the genetic syndrome of ventricular preexcitation and conduction system disease with childhood onset and absence of cardiac hypertrophy. Circulation 104: 3030-3033.
18. Gollob, M.H., Green, M.S., Tang, A.S., and Roberts, R. 2002. PRKAG2 cardiac syndrome: Familial ventricular preexcitation, conduction system disease, and cardiac hypertrophy. Curr. Opin. Cardiol. 17: 229-234.
19. 1 subunit of the AMP-activated protein kinase, FEBS Lett. 500: 163-168.
20. Hardie, D.G. and Hawley, S.A. 2001. AMP-activated protein kinase: The energy charge hypothesis revisited. Bioessays 23: 1112-1119.
21. Hardie, D.G., Salt, I.P., Hawley, S.A., and Davies, S.P. 1999. AMP-activated protein kinase: An ultrasensitive system for monitoring cellular energy charge. Biochem. J. 338: 717-722.
22. Hawley, S.A., Selbert, M.A., Goldstein, E.G., Edelman, A.M., Carling, D., and Hardie, D.G. 1995. 5′-AMP activates the AMP-activated protein kinase cascade, and Ca2+/calmodulin activates the calmodulin-dependent protein kinase I cascade, via three independent mechanisms. J. Biol. Chem. 270: 27186-27191.
23. Hawley, S.A., Davison, M., Woods, A., Davies, S.P., Beri, R.K., Carling, D., and Hardie, D.G. 1996. Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J. Biol. Chem. 271: 27879-27887.
24. Hawley, S.A., Gadalla, A.E., Olsen, G.S., and Hardie, D.G. 2002. The antidiabetic drug metformin activates the AMP-activated protein kinase cascade via an adenine nucleotide-independent mechanism. Diabetes 51: 2420-2425.
25. Hong, S.P., Leiper, F.C., Woods, A., Carling, D., and Carlson, M. 2003. Activation of yeast Snfl and mammalian AMP-activated protein kinase by upstream kinases. Proc. Natl. Acad. Sci. 100: 8839-8843.
26. Janosik, M., Kery, V., Gaustadnes, M., Maclean, K.N., and Kraus, J.P. 2001. Regulation of human cystathionine β-synthase by S-adenosyl-L-methionine: Evidence for two catalytically active conformations involving an autoinhibitory domain in the C-terminal region. Biochemistry 40: 10625-10633.
27. Kawaguchi, T., Osatomi, K., Yamashita, H., Kabashima, T., and Uyeda, K. 2002. Mechanism for fatty acid "sparing" effect on glucose-induced transcription: Regulation of carbohydrate-responsive element-binding protein by AMP-activated protein kinase. J. Biol. Chem. 277: 3829-3835.
28. Kemp, B.E., Stapleton, D., Campbell, D.J., Chen, Z.P., Murthy, S., Walter, M., Gupta, A., Adams, A.J., Katsis, F., van Denderen, B., et al. 2003. AMP-activated protein kinase, super metabolic regulator. Biochem. Soc. Trans. 31: 162-168.
29. Kluijtmans, L.A., Boers, G.H., Stevens, E.M., Renier, W.O., Kraus, J.P., Trijbels, F.J., van den Heuvel, L.P., and Blom, H.J. 1996. Defective cystathionine β-synthase regulation by S-adenosylmethionine in a partially pyridoxine responsive homocystinuria patient. J. Clin. Invest. 98: 285-289.
30. Krebs, E.G. 1954. The effect of salmine on the activity of phosphorylase. Biochim. Biophys. Acta 15: 508-515.
31. Leclerc, I., Lenzner, C., Gourdon, L., Vaulont, S., Kahn, A., and Viollet, B. 2001. Hepatocyte nuclear factor-4α involved in type 1 maturity-onset diabetes of the young is a novel target of AMP-activated protein kinase. Diabetes 50: 1515-1521.
32. Leff, T. 2003. AMP-activated protein kinase regulates gene expression by direct phosphorylation of nuclear proteins. Biochem. Soc. Trans. 31: 224-227.
33. Lo, W.S., Duggan, L., Tolga, N.C., Emre, Belotserkovskya, R., Lane, W.S., Shiekhattar, R., and Berger, S.L. 2001. Snf1-A histone kinase that works in concert with the histone acetyltransferase Gcn5 to regulate transcription. Science 293: 1142-1146.
34. Milan, D., Jeon, J.T., Looft, C., Amarger, V., Robic, A., Thelander, M., Rogel-Gaillard, C., Paul, S., Iannuccelli, N., Rask, L., et al. 2000. A mutation in PRKAG3 associated with excess glycogen content in pig skeletal muscle. Science 288: 1248-1251.
35. Minokoshi, Y., Kim, Y.B., Peroni, OD., Fryer, L.G., Muller, C., Carling, D., and Kahn, B.B. 2002. Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase. Nature 415: 339-343.
36. Mitchelhill, K.I., Stapleton, D., Gao, G., House, C., Michell, B., Katsis, F., Witters, L.A., and Kemp, B.E. 1994. Mammalian AMP-activated protein kinase shares structural and functional homology with the catalytic domain of yeast Snf1 protein kinase. J. Biol. Chem. 269: 2361-2364.
37. Morris, G.M., Goodsell, D.S., Halliday, R.S., Huey, R., Hart, W.E., Belew, R.K., and Olson, A.J. 1998. Automated docking using a Lamarckian genetic algorithm and and empirical binding free energy function. J. Comput. Chem. 19: 1639-1662.
38. Moule, S.K. and Denton, R.M. 1998. The activation of p38 MAPK by the β-adrenergic agonist isoproterenol in rat epididymal fat cells. FEBS Lett. 439: 287-290.
39. Nicholls, A., Sharp, K.A., and Honig, B. 1991. Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons. Proteins 11: 281-296.
40. Park, S.H., Gammon, S.R., Knippers, J.D., Paulsen, S.R., Rubink, D.S., and Winder, W.W. 2002. Phosphorylation-activity relationships of AMPK and acetyl-CoA carboxylase in muscle. J. Appl. Physiol. 92: 2475-2482.
41. Peitsch, M.C. 1996. SWISS-MODEL: An automated comparative protein modeling server and a model repository. Fold. Des. 1: S48-S49.
42. Rath, V.L., Ammirati, M., LeMotte, P.K., Fennell, K.F., Mansour, M.N., Danley, D.E., Hynes, T.R., Schulte, G.K., Wasilko, D.J., and Pandit, J. 2000. Activation of human liver glycogen phosphorylase by alteration of the secondary structure and packing of the catalytic core. Mol. Cell 6: 139-148.
43. Roussel, A., Fontecilla-Camps, J.C., and Cambillau, C. 1990. CRYStallize: A crystallographic symmetry display and handling subpackage in TOM/FRODO. J. Mol. Graphics 8: 86-88, 91.
44. Scott, J.W., Hawley, S.A., Green, K.A., Anis, M., Stewart, G., Scullion, G.A., Norman, D.G. and Hardie, D.G. 2003. CBS domains form energy-sensing modules whose binding of adenosine ligands is disrupted by disease mutations. J. Clin. Invest. (in press).
45. Sprang, S.R., Withers, S.G., Goldsmith, E.J., Fletterick, R.J., and Madsen, N.B. 1991. Structural basis for the activation of glycogen phosphorylase b by adenosine monophosphate. Science 254: 1367-1371.
46. Stoppani, J., Hildebrandt, A.L., Sakamoto, K., Cameron-Smith, D., Goodyear, L.J., and Neufer, P.D. 2002. AMP-activated protein kinase activates transcription of the UCP3 and HKI1 genes in rat skeletal muscle. Am. J. Physiol. 283:E1239-E1248.
47. Stultz, C.M., White, J.V., and Smith, T.F. 1993. Structural analysis based on state-space modeling. Protein Sci. 2: 305-314.
48. Wilson, W.A., Hawley, S.A., and Hardie, D.G. 1996. Glucose repression/derepression in budding yeast: SNFI protein kinase is activated by phosphorylation under derepressing conditions, and this correlates with a high AMP:ATP ratio. Curr. Biol. 6: 1426-1434.
49. Yamauchi, T., Kamon, J., Minokoshi, Y., Ito, Y., Waki, H., Uchida, S., Yamashita, S., Noda, M., Kita, S., Ueki, K., et al. 2002. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med. 8: 1288-1295.
50. Zhang, R., Evans, G., Rotella, F.J., Westbrook, E.M., Beno, D., Huberman, E., Joachimiak, A., and Collart, F.R. 1999. Characteristics and crystal structure of bacterial inosine-5′-monophosphate dehydrogenase. Biochemistry 38: 4691-4700.
51. Zheng, D., MacLean, P.S., Pohnert, S.C., Knight, J.B., Olson, A.L., Winder, W.W., and Dohm, G.L. 2001. Regulation of muscle GLUT-4 transcription by AMP-activated protein kinase. J. Appl. Physiol. 91: 1073-1083.
52. Zhou, M., Lin, B.Z., Coughlin, S., Vallega, G., and Pilch, P.F. 2000. UCP-3 expression in skeletal muscle: Effects of exercise, hypoxia, and AMP-activated protein kinase. Am. J. Physiol. 279: E622-E629.